These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37778047)

  • 1. Thrombocyte transfusion and rebleeding rate in patients using antiplatelet agents before aneurysmal subarachnoid hemorrhage.
    Sebök M; Zaugg N; Keller E; Willms J; Regli L; Germans M
    Neurosurg Focus; 2023 Oct; 55(4):E13. PubMed ID: 37778047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome.
    Sebök M; Hostettler IC; Keller E; Rautalin IM; Coert BA; Vandertop WP; Post R; Sardeha A; Tjerkstra MA; Regli L; Verbaan D; Germans MR
    Int J Stroke; 2022 Jun; 17(5):545-552. PubMed ID: 34282988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Aneurysmal Subarachnoid Hemorrhage Patients with Antiplatelet Use Before the Initial Hemorrhage: An International Survey.
    Sebök M; Keller E; van Niftrik CHB; Regli L; Germans MR
    World Neurosurg; 2018 Dec; 120():e408-e413. PubMed ID: 30149168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet transfusion in patients with aneurysmal subarachnoid hemorrhage is associated with poor clinical outcome.
    Post R; Tjerkstra MA; Middeldorp S; Van den Berg R; Roos YBWEM; Coert BA; Verbaan D; Vandertop WP
    Sci Rep; 2020 Jan; 10(1):856. PubMed ID: 31964972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The path from ictus to Neurosurgery: chronology and transport logistics of patients with aneurysmal subarachnoid haemorrhage in the South-Eastern Norway Health Region.
    Sorteberg A; Bredmose PP; Hansen AE; Sorteberg W
    Acta Neurochir (Wien); 2019 Aug; 161(8):1497-1506. PubMed ID: 31197472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Glucose-Potassium Ratio Predicts Preoperative Rebleeding in Patients With Aneurysmal Subarachnoid Hemorrhage.
    Wang J; Feng Q; Zhang Y; Qiu W; Gao H
    Front Neurol; 2021; 12():795376. PubMed ID: 35095738
    [No Abstract]   [Full Text] [Related]  

  • 7. Time intervals from subarachnoid hemorrhage to rebleed.
    Germans MR; Coert BA; Vandertop WP; Verbaan D
    J Neurol; 2014 Jul; 261(7):1425-31. PubMed ID: 24807086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of distance and transport method on intervention and mortality in aneurysmal subarachnoid hemorrhage.
    Weyhenmeyer J; Guandique CF; Leibold A; Lehnert S; Parish J; Han W; Tuchek C; Pandya J; Leipzig T; Payner T; DeNardo A; Scott J; Cohen-Gadol AA
    J Neurosurg; 2018 Feb; 128(2):490-498. PubMed ID: 28186453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic agent usage before ictus in aneurysmal subarachnoid hemorrhage: relation to hemorrhage severity, clinical course, and outcome.
    Kultanen H; Lewén A; Ronne-Engström E; Enblad P; Svedung Wettervik T
    Acta Neurochir (Wien); 2023 May; 165(5):1241-1250. PubMed ID: 36917361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemorrhage associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on a regimen of dual antiplatelet therapy: a retrospective analysis.
    Hudson JS; Nagahama Y; Nakagawa D; Starke RM; Dlouhy BJ; Torner JC; Jabbour P; Allan L; Derdeyn CP; Greenlee JDW; Hasan D
    J Neurosurg; 2018 Oct; 129(4):916-921. PubMed ID: 29125410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.
    Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G
    J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.
    Giede-Jeppe A; Reichl J; Sprügel MI; Lücking H; Hoelter P; Eyüpoglu IY; Kuramatsu JB; Huttner HB; Gerner ST
    J Neurosurg; 2019 Feb; 132(2):400-407. PubMed ID: 30717052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy.
    Wallace AN; Kayan Y; Almandoz JED; Mulder M; Milner AA; Scholz JM; Stiernagle K; Contestabile E; Tipps ME
    Clin Neurol Neurosurg; 2020 Aug; 195():106038. PubMed ID: 32650208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.
    Ditz C; Machner B; Schacht H; Neumann A; Schramm P; Tronnier VM; Küchler J
    Neurosurg Rev; 2021 Oct; 44(5):2899-2912. PubMed ID: 33492514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study.
    van Donkelaar CE; Bakker NA; Veeger NJ; Uyttenboogaart M; Metzemaekers JD; Luijckx GJ; Groen RJ; van Dijk JM
    Stroke; 2015 Aug; 46(8):2100-6. PubMed ID: 26069261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage.
    Zhao B; Yang H; Zheng K; Li Z; Xiong Y; Tan X; Zhong M;
    J Neurosurg; 2017 Jun; 126(6):1764-1771. PubMed ID: 27367238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pre-ictal antiplatelet therapy use in aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Ogulnick J; Feldstein E; Damodara N; Bravo M; Alshammari H; Dominguez J; Cooper J; Huang KT; Marikunte S; Ali S; Patel V; Khandelwal P; Mayer SA; Amuluru K; Gandhi CD
    Clin Neurol Neurosurg; 2021 Dec; 211():107022. PubMed ID: 34781219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
    Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
    J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean Platelet Volume/Platelet Count Ratio is Associated with Poor Clinical Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Wang Z; Pei W; Chen L; Ning Y; Luo Y
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105208. PubMed ID: 33066948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.